Research Options:

Week of Expected Pricing Withdrawn
Company Name Cardiodx, Inc.
Proposed Ticker CDX
CUSIP 14161A103
Business Description A molecular diagnostics company developing and commercializing novel, proprietary tests that help improve treatment decisions, enhance patient outcomes and reduce the overall cost of care. We use genomic chnologies to provide healthcare professionals with critical, actionable information to improve patient care and management.
Lead Underwriter BofA Merrill Lynch, Jefferies LLC.
Co-Managers Piper Jaffray & Co. William Blair and Co., L.L.C.
Initial Shares 5,000,000
Revised Initial Shares N/A
Initial Price $14.00-$16.00
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 

   
  © 2024 ICE Data Services. All rights reserved.